LofosTM

Calcium Acetate
Hyperphosphatemia products (Hyperphosphatemia products)

Indication:
LofosTM is indicated for the treatment and prevention of hyperphosphatemia in patients in end stage renal failure on dialysis.

Dosage & Administration:
The recommended initial dose of LofosTM for the adult dialysis patient is 2 tablets with each meal.

The dosage may be increased gradually to bring the serum phosphate level below 6 mg/dl, as long as hypercalcemia does not develop.

Most patients require 3-4 tablets with each meal.

Preparation:
Each box contains 60 tablets in blister pack.



  • Products By Trade Name

  • Products By Generic

  • Products By Therapeutic Class

  • Herbal & Nutraceuticals

  • AgroVet & Pesticides